XML 39 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Collaboration Agreements (Tables)
6 Months Ended
Jul. 03, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Collaborative Revenues Under Collaboration Agreement
Revenues under the collaboration agreement with Ipsen were as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2020
 
2019
 
2020
 
2019
License revenues
$
33,597

 
$
14,946

 
$
51,546

 
$
28,909

Collaboration services revenues
19,320

 
7,303

 
30,407

 
15,208

Total
$
52,917

 
$
22,249

 
$
81,953

 
$
44,117

 
 
 
 
 
 
 
 

License revenues under the collaboration agreement with Genentech were as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2020
 
2019
 
2020
 
2019
Profits on U.S. commercialization
$
1,376

 
$
1,349

 
$
2,783

 
$
2,404

Royalty revenues on ex-U.S. sales
$
1,125

 
$
1,323

 
$
2,434

 
$
2,813


Revenues under the collaboration agreement with Takeda were as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2020
 
2019
 
2020
 
2019
License revenues
$
22,946

 
$

 
$
22,946

 
$
9,056

Collaboration services revenues
2,195

 
1,565

 
3,264

 
4,002

Total
$
25,141

 
$
1,565

 
$
26,210

 
$
13,058